Announcing Dexcel Pharma USA, formerly known as Edenbridge Pharmaceuticals, LLC.

Amantadine Hydrochloride Tablets Approval

Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Amantadine Hydrochloride Tablets, 100mg, a generic version of Symmetrel®* Tablets, 100mg. Amantadine Hydrochloride Tablets, 100mg, are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine Hydrochloride Tablets, 100mg, are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. For more information please contact the Company directly at info@dexcelpharmausa.com.

Specialty Products

To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.